1. American Association on Mental Retardation. Mental retardation definition, classification, and systems of supports.
10th ed. Washington, DC: American Association on Mental Retardation; 2002.
2. Schalock RL, Luckasson R. American Association on Mental Retardation’s definition,
classification, and system of supports and its relation to international
trends and issues in the field of intellectual disabilities. J Policy Pract Intellect Disabil. 2004;1(3/4):136–146.
3. Bradley EA, Thompson A, Bryson SE. Mental retardation in teenagers: prevalence data from the Niagara
region, Ontario. Can J Psychiatry. 2002;47(7):652–659. [PubMed] 4. Leonard H, Wen X. The epidemiology of mental retardation: challenges and
opportunities in the new millennium. Ment Retard Dev Disabil Res Rev. 2002;8(3):117–134. [PubMed] 5. Polder JJ, Meerding WJ, Bonneux L, van der Maas PJ. Healthcare costs of intellectual disability in the Netherlands: a
cost-of-illness perspective. J Intellect Disabil Res. 2002;46(Pt 2):168–178. [PubMed] 6. The Surgeon General [United States] Closing the gap: a national blueprint to improve the health of persons
with mental retardation. Washington, DC: US Department of Health and Human Services, Office of the
Surgeon General; 2002. [cited 2006 January 22]. Available from: http://www.surgeongeneral.gov/topics/mentalretardation/
8. Ouellette-Kuntz H, Garcin N, Lewis MES, Minnes P, Martin C, Holden JJA. Addressing health disparities through promoting equity for
individuals with intellectual disability. Can J Public Health. 2005;96(Suppl 2):8–22.
9. Beange H, McElduff A, Baker W. Medical disorders of adults with mental retardation: a population
study. Am J Ment Retard. 1995;99(6):595–604. [PubMed] 10. Fisher K. Health disparities and mental retardation. J Nurs Scholarsh. 2004;36(1):48–53. [PubMed] 11. Cowan JA, Heckerling PS, Parker JB. Effect of a fact sheet reminder on performance of the periodic
health examination: a randomized controlled trial. Am J Prev Med. 1992;8(2):104–109. [PubMed]
12. Martin G. Support for people with learning disabilities: the role of
primary care. Prim Care Community Psychiatry. 2005;10(4):133–142.
13. Lennox N, Taylor M, Rey-Conde T, Bain C, Purdie DM, Boyle F. Beating the barriers: recruitment of people with intellectual
disability to participate in research. J Intellect Disabil Res. 2005;49(Pt 4):296–305. [PubMed] 14. Linehan C, Walsh PN, van Schrojenstein Lantman-de Valk H, Kerr M. POMONA: health indicators for people with intellectual disability in the
member states. Final report, November 2002 to October 2004. Dublin, Ireland: POMONA Project; 2004. [cited 2006 October 7]. p. 6. Available from: http://www.pomonaproject.org/pomona2_interim_4_report.pdf.
15. Berman LC, Freeman L, Helm DT. People and programs. In: Rubin IL, Crocker AC, editors.
Medical care for children and adults with developmental
disabilities. 2nd ed. Baltimore, Md: Paul H. Brookes
Publishing Co; 2006. pp. 43–56.
16. Heller T, Miller AB, Hsieh K, Sterns H. Later-life planning: promoting knowledge of options and
choice-making. Ment Retard. 2000;38(5):395–406. [PubMed] 17. Dubey V, Glazier R. Preventive Care Checklist Form©. Evidence-based tool
to improve preventive health care during complete health assessment of
adults. Can Fam Physician. 2006;52:48–55. [PMC free article] [PubMed]
19. Henderson CM. Genetically-linked syndromes in intellectual disabilities. J Policy Pract Intellect Disabil. 2004;1(1):31–41.
20. Cassidy SB, Allanson JE. Management of genetic syndromes. 2nd ed. New York, NY: Wiley-Liss; 2005.
21. Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, et al. Evaluation of mental retardation: recommendations of a Consensus
Conference: American College of Medical Genetics. Am J Med Genet. 1997;72(4):468–477. [PubMed]
22. Lennox N. (Developmental Disability Steering Group). Management guidelines developmental disability. In: Preventive health
care and health promotion. Version 2, 2005 ed. Melbourne, Australia: Therapeutic Guidelines; 2005. pp. 1–345.
23. Bhaumik S, Brantford D. The Frith prescribing guidelines for adults with learning disability. London, England: Taylor & Francis; 2005. p. 5. 5-7, 27-43, 107-17.
24. Rush AJ, Frances A. Guideline 4: medication treatment: general principles. Expert
Consensus Guideline Series: treatment of psychiatric and behavioral problems
in mental retardation. Am J Ment Retard. 2000;105(3):178–181.
25. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate
medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–2724. [PubMed]
26. Beange H, Lennox N, Parmenter TR. Health targets for people with intellectual disability. J Intellect Dev Disabil. 1999;24(4):283–297.
27. Radouco-Thomas M, Bolduc M, Brisson A, Brassard P, Fortier L, Thivierge J. Pilot study on the use of psychotropic medication in persons with
mental retardation. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(5):879–883. [PubMed] 28. Horner-Johnson W, Drum CE. Prevalence of maltreatment of people with intellectual
disabilities: a review of recently published research. Ment Retard Dev Disabil Res Rev. 2006;12(1):57–69. [PubMed]
31. Meijer MM, Carpenter S, Scholte FA. European manifesto on basic standards of health care for people
with intellectual disabilities. J Policy Pract Intellect Disabil. 2004;1(1):10–15.
32. Friedman RI. Use of advance directives: facilitating health care decisions by
adults with mental retardation and their families. Ment Retard. 1998;36(6):444–456. [PubMed]
33. Heng J, Sullivan WF. Ethical issues relating to consent in providing treatment and care. In:
Brown I, Percy M, editors. Developmental disabilities in Ontario. 2nd ed. Toronto, Ont: Ontario Association on Developmental Disabilities; 2003. pp. 727–735.
34. Rush AJ, Frances A. Guideline 2: informed consent. Expert Consensus Guideline Series:
treatment of psychiatric and behavioral problems in mental retardation. Am J Ment Retard. 2000;105(3):169.
35. Crocker AC. Systems of medical care delivery. In: Rubin IL, Crocker AC,
editors. Medical care for children and adults with developmental
disabilities. 2nd ed. Baltimore, Md: Paul H. Brookes
Publishing Co; 2006. pp. 57–59.
36. Drotar DD, Sturm LA. Interdisciplinary collaboration in the practice of mental retardation.
In: Jacobson JW, Mulick JA, editors. Manual of diagnosis and professional
practice in mental retardation. Washington, DC: American Psychological Association; 1996. pp. 393–401.
37. Davis S, Wehmeyer ML, Board JP, Jr, Fox S, Maher F, Roberts B. Interdisciplinary teams. In: Reiss S, Aman MG, editors. Psychotropic
medications and developmental disabilities: the international handbook. Columbus, Ohio: Ohio State University Nisonger Center; 1998. pp. 73–94.
38. Stanish HI, Temple VA, Frey GC. Health-promoting physical activity of adults with mental
retardation. Ment Retard Dev Disabil Res Rev. 2006;12(1):13–21. [PubMed] 39. Rimmer JH, Yamaki K. Obesity and intellectual disability. Ment Retard Dev Disabil Res Rev. 2006;12(1):22–27. [PubMed] 40. Heller T, Hsieh K, Rimmer JH. Attitudinal and psychosocial outcomes of a fitness and health
education program on adults with Down syndrome. Am J Ment Retard. 2004;109(2):175–185. [PubMed] 43. Van Splunder J, Stilma JS, Bernsen RM, Evenhuis HM. Prevalence of ocular diagnoses found on screening 1539 adults
with intellectual disabilities. Ophthalmology. 2004;111(8):1457–1463. [PubMed]
44. Lowe C, Temple V. Identifying hearing loss in adults with developmental
disabilities. J Speech Lang Pathol Audiol. 2002;26(1):20–26.
45. Evenhuis HM, Natzgam LMD. IASSID international consensus statement: early identification of
hearing and visual impairment in children and adults with an intellectual
disability. Leiden, The Netherlands: International Association of Scientific Studies on Intellectual
Disability (IASSID), Special Interest Group on Health Issues; 1997. [cited 2006 January 22]. Available from: http://www.iassid.org/pdf/consensir.alg.doc. 46. Owens PL, Kerker BD, Zigler E, Horwitz SM. Vision and oral health needs of individuals with intellectual
disability. Ment Retard Dev Disabil Res Rev. 2006;12(1):28–40. [PubMed]
48. Wallace R. Risk factors for coronary artery disease among individuals with
rare syndrome intellectual disabilities. J Policy Pract Intellect Disabil. 2004;1(1):42–51.
49. Draheim CC. Cardiovascular disease prevalence and risk factors of persons
with mental retardation. Ment Retard Dev Disabil Res Rev. 2006;12(1):3–12. [PubMed]
50. Bezchlibnyk-Butler KZ, Jeffries JJ. Clinical handbook of psychotropic drugs. 16th ed. Seattle, Wash: Hogrefe & Huber Publishers; 2006. p. 111.
51. Patja K, Molsa P, Iivanainen M. Cause-specific mortality of people with intellectual disability
in a population-based, 35-year follow-up study. J Intellect Disabil Res. 2001;45(Pt 1):30–40. [PubMed] 52. Rogers B, Stratton P, Msall M, Andres M, Champlain MK, Koerner P, Piazza J. Long-term morbidity and management strategies of tracheal
aspiration in adults with severe developmental disabilities. Am J Ment Retard. 1994;98(4):490–498. [PubMed] 53. Bohmer CJ, Klinkenberg-Knol EC, Niezen-de Boer MC, Meuwissen SG. Gastroesophageal reflux disease in intellectually disabled
individuals: how often, how serious, how manageable? Am J Gastroenterol. 2000;95(8):1868–1872. [PubMed] 54. Bohmer CJ, Taminiau JA, Klinkenberg-Knol EC, Meuwissen SG. The prevalence of constipation in institutionalized people with
intellectual disability. J Intellect Disabil Res. 2001;45(Pt 3):212–218. [PubMed]
55. Wallace R, Schluter PJ, Duff M, Ouellette-Kuntz H, Webb PMSM. A review of the risk factors for, consequences, diagnosis, and
management of Helicobacter pylori in adults with
intellectual disabilities. J Policy Pract Intellect Disabil. 2004;1(3/4):147–163.
56. Van Blankenstein M, Bohmer CJ, Hop WC. The incidence of adenocarcinoma in Barrett’s esophagus in an
institutionalized population. Eur J Gastroenterol Hepatol. 2004;16(9):903–909. [PubMed]
57. McCarthy M. Sexuality. In: Walsh P, Heller T, editors. Health of women with
intellectual disabilities. Oxford, England: Blackwell Science; 2002. pp. 90–102.
58. Servais L. Sexual health care in persons with intellectual disabilities. Ment Retard Dev Disabil Res Rev. 2006;12(1):48–56. [PubMed] 59. Tyler CV, Jr, Snyder CW, Zyzanski S. Screening for osteoporosis in community-dwelling adults with
mental retardation. Ment Retard. 2000;38(4):316–321. [PubMed] 60. Bowley C, Kerr M. Epilepsy and intellectual disability. J Intellect Disabil Res. 2000;44(Pt 5):529–543. [PubMed] 61. Kelly K, Stephen LJ, Brodie MJ. Pharmacological outcomes in people with mental retardation and
epilepsy. Epilepsy Behav. 2004;5(1):67–71. [PubMed] 62. Hemmings CP, Gravestock S, Pickard M, Bouras N. Psychiatric symptoms and problem behaviours in people with
intellectual disabilities. J Intellect Disabil Res. 2006;50(Pt 4):269–276. [PubMed]
63. Bradley EA, Hollins S. Assessment of patients with intellectual disabilities. In: Goldbloom DS,
editor. Psychiatric clinical skills. Philadelphia, Pa: Mosby Elsevier; 2006. pp. 235–253.
64. Deb S, Thomas M, Bright C. Mental disorder in adults with intellectual disability. 1:
Prevalence of functional psychiatric illness among a community-based
population aged between 16 and 64 years. J Intellect Disabil Res. 2001;45(Pt 6):495–505. [PubMed] 65. Kerker BD, Owens PL, Zigler E, Horwitz SM. Mental health disorders among individuals with mental
retardation: challenges to accurate prevalence estimates. Public Health Rep. 2004;119(4):409–417. [PMC free article] [PubMed] 66. Division Of Mental Health And Prevention Of Substance Abuse, World
Health Organization. ICD-10 guide for mental retardation. Geneva, Switz: World Health Organization; 1996. [cited 2006 May 22]. Available from: http://www.who.int/mental_health/media/en/69.pdf.
67. Kalachnik JE, James DH, Sovner R, Kastner TA, Walsh K, Weisblatt SA, et al. Guidelines for the use of psychotropic medications. In: Reiss S, Aman
MG, editors. Psychotropic medications and developmental disabilities: the
international handbook. Columbus, Ohio: Ohio State University Nisonger Center; 1998. pp. 45–72.
68. Gardner WI, Graeber-Whalen JL, Ford DR. Behavioral therapies: individualizing interventions through treatment
formulations. In: Dosen A, Day K, editors. Treating mental illness and
behavior disorders in children and adults with mental retardation. Washington, DC: American Psychiatric Press; 2001. pp. 69–100.
69. McCabe MP, McGillivray JA, Newton DC. Effectiveness of treatment programmes for depression among adults
with mild/moderate intellectual disability. J Intellect Disabil Res. 2006;50(Pt 4):239–247. [PubMed]
70. Myers B. Psychotic disorders in people with mental retardation: diagnostic
and treatment issues. Ment Health Aspects Dev Disabil. 1999;2(1):1–11.
71. Deb S, Matthews T, Holt G, Bouras N. Practice guidelines for the assessment and diagnosis of mental health
problems in adults with intellectual disability. Cheapside, Brighton, UK: Pavilion Press; 2001. [cited 2006 September 20]. Available from: http://www.estiacentre.org/docs/PracticeGuidelines.pdf. 72. Holland AJ, Hon J, Huppert FA, Stevens F. Incidence and course of dementia in people with Down’s syndrome:
findings from a population-based study. J Intellect Disabil Res. 2000;44(Pt 2):138–146. [PubMed] 73. Janicki MP, Heller T, Seltzer GB, Hogg J. Practice guidelines for the clinical assessment and care
management of Alzheimer’s disease and other dementias among adults with
intellectual disability. AAMR-IASSID Workgroup on Practice Guidelines for
Care Management of Alzheimer’s Disease among Adults with Intellectual
Disability. J Intellect Disabil Res. 1996;40(Pt 4):374–382. [PubMed]
74. Bradley E, Lofchy J. Learning disability in the accident and emergency department. Adv Psychiatr Treat. 2005;11:45–57.
75. Bradley E, Summers J. Developmental disability and behavioural, emotional and psychiatric
disturbances. In: Brown I, Percy M, editors. Developmental disabilities in
Ontario. 2nd ed. Toronto, Ont: Ontario Association on Mental Retardation; 2003. pp. 751–774.
77. Rubin IL, Crocker AC. Medical care for children and adults with developmental
disabilities. 2nd ed. Baltimore, Md: Paul H. Brookes Publishing
78. Mickan S, Askew D. What sort of evidence do we need in primary care? BMJ. 2006;332(7542):619–620. [PMC free article] [PubMed]